AUS
NZ
UK
CA
USA
IND
Health
Is Xencor Redefining the Biopharmaceutical Landscape?
March 02, 2025 02:10 AM PST| By Team Kalkine MediaHighlights,Principal Financial Group Inc. raised its stake in Xencor (NASDAQ:XNCR) during a recent fiscal cycle.,Several institutional entities adjusted their share allocations by notable margins.,The company reported revenue expansion alongside a de...
Is Pediatrix Medical Group's Investor Base Expanding?
March 02, 2025 01:37 AM PST| By Team Kalkine MediaHighlights,Institutional investors are increasing stakes in Pediatrix Medical Group.,Financial performance shows an earnings beat and steady revenue.,A shift in investor composition is observed with notable share increases.,Pediatrix Medical Group, I...
Could Walgreens Boots Alliance Reshape Healthcare and Retail?
March 02, 2025 01:36 AM PST| By Team Kalkine MediaHighlights:,A prominent financial group adjusted its holdings, resulting in a structural change.,Institutional participants possess a significant portion of the company’s stock.,The company reported a solid increase in revenue amid market challenges....
Is Medpace Redefining Healthcare Services?
March 02, 2025 01:00 AM PST| By Team Kalkine MediaHighlights,Institutional stakeholders modify their positions with some reducing and others expanding their stakes.,The company operates within the outsourced clinical development sector for biotechnology, pharmaceuticals, and medical devices.,Recent...
Is the Healthcare Momentum ETF Experiencing a Turning Point?
March 02, 2025 01:00 AM PST| By Team Kalkine MediaHighlights,Global Retirement Partners LLC expanded its position significantly in the ETF.,Jaffetilchin Investment Partners LLC acquired a new sizeable stake in the ETF.,The ETF exhibited a modest share price increase with a moderate market capitaliza...
Is Skye Bioscience Leading the Way in Cannabinoid-Based Treatments?
March 02, 2025 12:25 AM PST| By Team Kalkine MediaHighlights,Coverage initiated by a prominent research firm with a favorable view,Notable institutional interest has grown in recent times,Focus on innovative cannabinoid-based therapies for eye conditions,Operating within the pharmaceutical and biote...
Has Summit Therapeutics Altered Its Market Position?
March 02, 2025 12:25 AM PST| By Team Kalkine MediaHighlights,Institutional investors have adjusted their stakes in the company,The firm is dedicated to developing novel therapies for difficult infections and diseases,Mixed market views characterize its current standing in the biopharmaceutical secto...
Can Biotech Innovation Revolutionize Eye Treatment Solutions?
March 02, 2025 12:25 AM PST| By Team Kalkine MediaHighlights,Skye Bioscience experienced a modest increase in stock value with shares opening near three dollars.,Several hedge funds and institutional investors have shown interest in the firm.,The company specializes in cannabinoid-based molecules fo...
How Is Biogen Inc. (NASDAQ:BIIB) Managing Institutional Investment Changes?
February 28, 2025 09:56 AM PST| By Team Kalkine MediaHighlights,Truist Financial Corp adjusted its holdings in Biogen Inc., reducing its stake during the fourth quarter.,Multiple institutional investors modified their positions, contributing to overall market activity.,Biogen Inc. continues to advance...
How Is TransMedics Group (NASDAQ:TMDX) Positioned Amid Institutional Investment Shifts?
February 28, 2025 09:44 AM PST| By Team Kalkine MediaHighlights,Principal Financial Group Inc. adjusted its holdings in TransMedics Group, reflecting changes in institutional ownership.,Institutional entities collectively hold a significant portion of the company's stock.,Stock movements and financial...
How Is AtriCure, Inc. (NASDAQ:ATRC) Gaining Market Confidence?
February 28, 2025 08:42 AM PST| By Team Kalkine MediaHighlights,AtriCure has received positive attention, with a target price set by research firms.,The company maintains strong financial health with a solid market cap and debt-to-equity ratio.,Institutional investors have expanded their positions, ref...
How Is LivaNova PLC (NASDAQ:LIVN) Positioned in the Medical Device Sector
February 28, 2025 08:24 AM PST| By Team Kalkine MediaHighlights,MannKind Corporation received multiple rating upgrades, reflecting changing market evaluations.,The company reported earnings aligning with projections, with revenue surpassing prior estimates.,Institutional firms and hedge funds hold a si...
Why Are Institutional Investors Adjusting Their Positions in Xencor Inc. (NASDAQ:XNCR)?
February 28, 2025 08:18 AM PST| By Team Kalkine MediaHighlights,Xencor Inc. has received varied ratings, with some financial firms maintaining their assessments while others adjusting their positions.,The company holds a strong balance sheet with significant cash reserves, despite reporting a negative...
How Are Financial Firms Responding to MannKind Corporation’s Performance (NASDAQ:MNKD)
February 28, 2025 08:16 AM PST| By Team Kalkine MediaHighlights,MannKind Corporation received multiple rating upgrades, reflecting changing market evaluations.,The company reported earnings aligning with projections, with revenue surpassing prior estimates.,Institutional firms and hedge funds hold a si...
Can Maze Therapeutics Transform Genetic Medicine?
February 27, 2025 10:25 PM PST| By Team Kalkine MediaHighlights,Maze Therapeutics is a clinical-stage biopharmaceutical company focused on precision medicines for renal, cardiovascular, and metabolic conditions.,The company leverages a proprietary Compass platform to connect genetic variants with disea...
Is Sharps Technology Facing a Drastic Shift in Short Interest?
February 27, 2025 10:25 PM PST| By Team Kalkine MediaHighlights,Short interest fell by more than seventy percent in mid-February.,The stock opened at four cents with stable moving averages.,Founded in 2017, the company focuses on safety syringe innovations.,Sharps Technology operates in the healthcare...
Can Biopharmaceutical Advancements Overcome Financial Hurdles?
February 27, 2025 10:25 PM PST| By Team Kalkine MediaHighlights:,A prominent research group revised first-quarter earnings per share estimates downward.,Recent earnings report recorded earnings per share below anticipated values with revenues modestly exceeding projections.,Diverse perspectives among f...
How Are Institutional Moves Shaping BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)’s Market Position
February 27, 2025 09:56 AM PST| By Team Kalkine MediaHighlights,Principal Securities Inc. increased its stake in BioMarin by 24% in Q4.,BioMarin exceeded earnings expectations with impressive revenue.,Market participants updated projections following BioMarin's results.,Institutional Activity and Growi...
Is Phathom Pharmaceuticals Gaining Ground in the Biopharmaceutical Market? (NASDAQ:PHAT)
February 27, 2025 09:54 AM PST| By Team Kalkine MediaHighlights,Phathom Pharmaceuticals has received positive sentiment from multiple firms.,The stock has shown volatility, with fluctuations in its 52-week range impacting market movements.,Institutional investors have significantly adjusted their holdi...
Myriad Genetics (NASDAQ:MYGN) Institutional Trends and Market Response
February 27, 2025 09:32 AM PST| By Team Kalkine MediaHighlights,Institutional investors adjusted their holdings in Myriad Genetics.,The company reported revenue growth in the latest quarter.,Myriad Genetics specializes in molecular diagnostic testing.,Institutional Activity and Market Movements,Myriad...
